Controlled release technology for anti-angiogenesis treatment of posterior eye diseases: Current status and...

Area of Science:

• Ophthalmology
• Biomaterials Science
• Drug Delivery Systems

Background:

• Current antiangiogenic therapies for retinal and choroidal neovascularization require frequent intravitreal injections, leading to poor patient compliance and suboptimal treatment outcomes.
• Emerging therapeutics like tyrosine kinase inhibitors and siRNAs face clinical translation challenges.
• Controlled release technology presents a strategy to overcome these limitations by extending drug duration and reducing injection frequency.

Purpose of the Study:

• To review the principles and mechanisms of polymeric reservoir, polymeric matrix, and hydrogel systems for controlled drug release in ocular applications.
• To analyze the design rationales of current drug delivery and release systems in preclinical and clinical stages for ocular angiogenesis.
• To critically evaluate animal models for ocular angiogenesis diseases to facilitate the translation of controlled release technologies.

Main Methods:

• Qualitative and quantitative discussions on controlled release mechanisms (polymeric reservoir, matrix, hydrogels).
• Review of existing drug delivery and release systems in preclinical and clinical studies.
• Critical analysis of animal models for ocular angiogenesis diseases.

Main Results:

• Detailed explanation of controlled release principles for ocular drug delivery.
• Insights into the design and application of current controlled release systems.
• Comprehensive review of relevant animal models for evaluating therapeutic efficacy.

Conclusions:

• Controlled release technologies can significantly improve the management of chronic ocular angiogenesis by enhancing therapeutic duration and patient compliance.
• Understanding the mechanisms of different controlled release systems is crucial for optimizing ocular drug delivery.
• Effective animal models are essential for the successful translation of novel controlled release technologies from research to clinical practice.